Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation

References

• Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2018 Report. Available from: www.goldcopd.orgAccessed January 2, 2018
   Google Scholar
• BarnesPJImmunology of asthma and chronic obstructive pulmonary diseaseNat Rev Immunol20088318319218274560
   PubMed Web of Science ®Google Scholar
• ChoudhuryGRabinovichRMacneeWComorbidities and systemic effects of chronic obstructive pulmonary diseaseClin Chest Med201435110113024507840
   PubMed Web of Science ®Google Scholar
• CorlateanuACovantevSMathioudakisAGBotnaruVSiafakasNPrevalence and burden of comorbidities in Chronic Obstructive Pulmonary DiseaseRespir Investig2016546387396
   PubMed Web of Science ®Google Scholar
• AgustíACalverleyPMDecramerMStockleyRAWedzichaJAPrevention of exacerbations in chronic obstructive pulmonary disease: knowns and unknownsChronic Obstr Pulm Dis20141216618428848819
   PubMedGoogle Scholar
• VinckenWDekhuijzenPRBarnesPADMIT GroupThe ADMIT series – Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPDPrim Care Respir J2010191102019890594
   PubMedGoogle Scholar
• LavoriniFInhaled drug delivery in the hands of the patientJ Aerosol Med Pulm Drug Deliv201427641441825238005
   PubMed Web of Science ®Google Scholar
• LavoriniFCorriganCJBarnesPJAerosol drug management improvement team. Retail sales of inhalation devices in European countries: so much for a global policyRespir Med20111051099110321489771
   PubMed Web of Science ®Google Scholar
• LaubeBLJanssensHMde JonghFHWhat the pulmonary specialist should know about the new inhalation therapiesEur Respir J20113761308141721310878
   PubMed Web of Science ®Google Scholar
• ChrystynHIs inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these ratesRespir Med200397218118712587970
   PubMed Web of Science ®Google Scholar
• SanchisJCorriganCLevyMLViejoJLADMIT GroupInhaler devices – from theory to practiceRespir Med2013107449550223290591
   PubMed Web of Science ®Google Scholar
• AzouzWChrystynHClarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practicePrim Care Respir J201221220821322336894
   PubMedGoogle Scholar
• LavoriniFManniniCChelliniEFontanaGAOptimising inhaled pharmacotherapy for elderly patients with chronic obstructive pulmonary disease: the importance of delivery devicesDrugs Aging201633746147327216613
   PubMed Web of Science ®Google Scholar
• RoglianiPCalzettaLCoppolaAOptimizing drug delivery in COPD: The role of inhaler devicesRespir Med201712461428284323
   PubMed Web of Science ®Google Scholar
• LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
   PubMed Web of Science ®Google Scholar
• MelzerACGhassemiehBJGillespieSEPatient characteristics associated with poor inhaler technique among a cohort of patients with COPDRespir Med201712312413028137488
   PubMed Web of Science ®Google Scholar
• MelaniASBonaviaMCilentiVOn behalf of the Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri (AIPO). Inhaler mishandling remains common in real life and is associated with reduced disease controlRespir Med201110593093821367593
   PubMed Web of Science ®Google Scholar
• PriceDBRomán-RodríguezMMcqueenRBInhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomesJ Allergy Clin Immunol Pract2017541071108128286157
   PubMed Web of Science ®Google Scholar
• SanchisJGichIPedersenSOn behalf of the Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: has patient technique improved over time?Chest2016150239440627060726
   PubMed Web of Science ®Google Scholar
• ChrystynHPriceDBMolimardMComparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label studyBMC Pulm Med2016161226769482
   PubMed Web of Science ®Google Scholar
• BraidoFChrystynHBaiardiniI“Trying, But Failing” – The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication AdherenceJ Allergy Clin Immunol Pract20164582383227587316
   PubMed Web of Science ®Google Scholar
• PriceDKeiningerDLViswanadBGasserMWaldaSGutzwillerFSFactors associated with appropriate inhaler use in patients with COPD – lessons from the REAL surveyInt J COPD201813695702
   Google Scholar
• VrijensBDimaALvan GanseEWhat we mean when we talk about adherence in respiratory medicineJ Allergy Clin Immunol Pract20164580281227587314
   PubMed Web of Science ®Google Scholar
• SharmaGMahlerDAMayorgaVMDeeringKLHarshawOGanapathyVPrevalence of low peak inspiratory flow rate at discharge in patients hospitalized for COPD exacerbationChronic Obstr Pulm Dis20174321722428848933
   PubMed Web of Science ®Google Scholar
• MolimardMRaherisonCLignotSChronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patientsEur Respir J2017492160179428182569
   PubMed Web of Science ®Google Scholar
• LohCHPetersSPLovingsTMOharJASuboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissionsAnn Am Thorac Soc20171481305131128406710
   PubMed Web of Science ®Google Scholar
• JanssensWVandenbrandePHardemanEInspiratory flow rates at different levels of resistance in elderly COPD patientsEur Respir J2008311788317898020
   PubMed Web of Science ®Google Scholar
• MahlerDAWatermanLAGiffordAHPrevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhalerJ Aerosol Med Pulm Drug Deliv201326317417923025451
   PubMed Web of Science ®Google Scholar
• KawamatawongTKhiawwanSPornsuriyasakPPeak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseasesJ Asthma Allergy201710172128260934
   PubMed Web of Science ®Google Scholar
• MalmbergLPRytiläPHapponenPHaahtelaTInspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity mattersInt J Chron Obstruct Pulmon Dis2010525726220714380
   PubMedGoogle Scholar
• SeheultJNCostelloSTeeKCInvestigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional studySpringerplus2014349649625279290
   PubMedGoogle Scholar
• van der PalenJPeak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL)Respir Med200397328528912645837
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (2017 Report) Available from: www.goldcopd.orgAccessed January 2, 2018
   Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• Alliance Tech Medical [homepage on the Internet]: In-Check inspiratory flow measurement device Available from: http://www.alliancetech-medical.com/products/check-inspiratory-flow-measurement-device/Accessed January 2, 2018
   Google Scholar
• KendrickKRBaxiSCSmithRMUsefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthmaJ Emerg Nurs200026321622210839848
   PubMedGoogle Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• ChenRChenRChenXChenLEffect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary diseaseIntern Med J201444879180024860934
   PubMed Web of Science ®Google Scholar
• JarvisSIndPWShinerRJInhaled therapy in elderly COPD patients; time for re-evaluation?Age Ageing200736221321817267450
   PubMed Web of Science ®Google Scholar
• FranssenFMWoutersEFScholsAMThe contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseasesClin Nutr2002211114
   PubMed Web of Science ®Google Scholar
• EnrightPLKronmalRAManolioTASchenkerMBHyattRERespiratory muscle strength in the elderly. Correlates and reference values. Cardiovascular Health Study Research GroupAm J Respir Crit Care Med19941492 Pt 14304388306041
   PubMed Web of Science ®Google Scholar
• DemolyPHagedoornPde BoerAHFrijlinkHWThe clinical relevance of dry powder inhaler performance for drug deliveryRespir Med201410881195120324929253
   PubMed Web of Science ®Google Scholar
• GhoshSOharJADrummondMBPeak inspiratory flow rate in chronic obstructive pulmonary disease: implications for dry powder inhalersJ Aerosol Med Pulm Drug Deliv201730638138728933581
   PubMed Web of Science ®Google Scholar
• LevineSKaiserLLeferovichJTikunovBCellular adaptations in the diaphragm in chronic obstructive pulmonary diseaseN Engl J Med199733725179918069400036
   PubMed Web of Science ®Google Scholar
• GosselinkRTroostersTDecramerMDistribution of muscle weakness in patients with stable chronic obstructive pulmonary diseaseJ Cardiopulm Rehabil200020635336011144041
   PubMedGoogle Scholar